Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study
If proven efficacious in randomized trials and cost-effective, screening for HPV-positive oropharyngeal cancers could provide considerable population-level reductions in advanced stage cancers, treatment-related morbidities, and mortality.
Authors
- Hormuzd A. Katki (ORCID: https://orcid.org/0000-0003-2002-0095)
- Emily Annika Burger (ORCID: https://orcid.org/0000-0002-6657-5849)
- Nicole G. Campos (ORCID: https://orcid.org/0000-0002-0840-4339)
- Anil K. Chaturvedi (ORCID: https://orcid.org/0000-0003-2696-8899)
- Li C. Cheung (ORCID: https://orcid.org/0000-0003-1625-4331)
- Gregory Haber (ORCID: https://orcid.org/0000-0002-8555-1850)
- Rebecca Landy (ORCID: https://orcid.org/0000-0003-4042-4820)
- Barry I. Graubard (ORCID: https://orcid.org/0000-0002-6787-1105)
- Carole Fakhry (ORCID: https://orcid.org/0000-0002-5251-6178)
- Maura L. Gillison (ORCID: https://orcid.org/0000-0002-8145-5749)
Institutions
- National Institute of Standards and Technology (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Johns Hopkins University (US)
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Johns Hopkins Medicine (US)
- Information Technology Laboratory (US)
- National Cancer Institute (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1093/jnci/djaf033
- Citations
- 4
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.39
Funders
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health
- National Cancer Institute